Industry Experts

Connie Tat is a scientist passionate about translating innovative research to impact patient lives. Connie has 9+ years of experience in biopharma across research, medical, and commercial.  She is currently a Senior Medical Science Director in oncology at Genentech and involved in a clinical trial which uses ctDNA as a biomarker to select for bladder cancer patients that need treatment.  Previously she was at Amgen, where she launched LUMAKRAS, a first in class KRAS G12C targeted therapy in lung cancer.  Connie received a Ph.D. in Immunology from UC Irvine and a Bachelor’s in Molecular and Cellular Biology from UC Berkeley.